The Korean Genetic Diagnosis Program for Rare Disease Phase II: outcomes of a 6-year national project

被引:2
|
作者
Kim, Man Jin [1 ]
Kim, Boram [2 ]
Lee, Heerah [2 ]
Lee, Jee-Soo [2 ]
Chae, Seung Won [2 ,3 ]
Shin, Ho Seob [2 ]
Cho, Sung Im [2 ]
Kim, Soo Yeon [4 ]
Moon, Jangsup [1 ]
Lim, Byung Chan [4 ]
Ko, Jung Min [4 ]
Chae, Jong-Hee [1 ,4 ]
Park, Sung Sup [2 ]
Seong, Moon-Woo [2 ]
机构
[1] Seoul Natl Univ Hosp, Dept Genom Med, Seoul, South Korea
[2] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Lab Med, Coll Med, Seoul, South Korea
[3] Seoul Natl Univ, Canc Res Inst, Coll Med, Seoul, South Korea
[4] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Pediat, Coll Med, Seoul, South Korea
关键词
GUIDELINES;
D O I
10.1038/s41431-023-01415-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Korean Genetic Diagnosis Program for Rare Disease (KGDP) enrolled 1890 patients with rare diseases between March 2017 and October 2022. Children and adolescents accounted for the majority of the patients, and systemic disease was the most common presenting symptom. The exome-based virtual disease-specific multigene panel was the most frequently used analytical method, with an overall diagnostic yield of 33.3%. A total of 629 positive cases were diagnosed, involving 297 genes. All 297 genes identified in these cases were confirmed to be known genes listed in the OMIM database. The nationwide KGDP network and its cooperation with the Korean Undiagnosed Diseases Program (KUDP) provide a more comprehensive genetic analysis of undiagnosed cases. The partnership between the KGDP and KUDP has the potential to improve the diagnosis and treatment options for patients. In conclusion, KGDP serves as the primary access point or gateway to KUDP.
引用
收藏
页码:1147 / 1153
页数:7
相关论文
共 50 条
  • [1] The Korean Genetic Diagnosis Program for Rare Disease Phase II: outcomes of a 6-year national project
    Man Jin Kim
    Boram Kim
    Heerah Lee
    Jee-Soo Lee
    Seung Won Chae
    Ho Seob Shin
    Sung Im Cho
    Soo Yeon Kim
    Jangsup Moon
    Byung Chan Lim
    Jung Min Ko
    Jong-Hee Chae
    Sung Sup Park
    Moon-Woo Seong
    European Journal of Human Genetics, 2023, 31 : 1147 - 1153
  • [2] MEDICATION CONTRACT VIOLATIONS: 6-YEAR OUTCOMES IN A PRIMARY CARE CHRONIC PAIN PROGRAM
    Chelminski, P.
    Hayes, K.
    Ives, T. J.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2009, 24 : 121 - 122
  • [3] FORGE Canada Consortium: Outcomes of a 2-Year National Rare-Disease Gene-Discovery Project
    Beaulieu, Chandree L.
    Majewski, Jacek
    Schwartzentruber, Jeremy
    Samuels, Mark E.
    Femandez, Bridget A.
    Bernier, Francois P.
    Brudno, Michael
    Knoppers, Bartha
    Marcadier, Janet
    Dyment, David
    Adam, Shelin
    Bulman, Dennis E.
    Jones, Steve J. M.
    Avard, Denise
    Minh Thu Nguyen
    Rousseau, Francois
    Marshall, Christian
    Wintle, Richard F.
    Shen, Yaoqing
    Scherer, Stephen W.
    Friedman, Jan M.
    Michaud, Jacques L.
    Boycott, Kym M.
    AMERICAN JOURNAL OF HUMAN GENETICS, 2014, 94 (06) : 809 - 817
  • [4] Do Management Strategies for Coronary Artery Disease Influence 6-Year Cognitive Outcomes?
    Selnes, Ola A.
    Grega, Maura A.
    Bailey, Maryanne M.
    Pham, Luu D.
    Zeger, Scott L.
    Baumgartner, William A.
    McKhann, Guy M.
    ANNALS OF THORACIC SURGERY, 2009, 88 (02): : 445 - U132
  • [5] Buschke-Ollendorff syndrome in a 6-year old patient: clinical and histopathological aspects of a rare disease
    Diotallevi, Federico
    Simonetti, Oriana
    Radi, Giulia
    Martina, Emanuela
    Paolinelli, Matteo
    Sapigni, Claudia
    Guanciarossa, Francesca
    Bianchelli, Tommaso
    Brancorsini, Donatella
    Offidani, Annamaria
    ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA, 2020, 29 (01): : 31 - 33
  • [6] STEPS-T Program Improves Endovascular Treatment Outcomes of Acute Ischemic Stroke; A 6-Year Study
    Hassan, Ameer E.
    Rabah, Rani R.
    Preston, Laurie
    Tekle, Wondwossen G.
    FRONTIERS IN NEUROLOGY, 2020, 10
  • [7] Recruitment, outcomes and toxicity trends in phase I oncology trials: 6-year experience in a large institution
    Menon, Siddharth
    Davies, Amy
    Frentzas, Sophia
    Hawkins, Chery-Ann
    Segelov, Eva
    Day, Daphne
    Markman, Ben
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 : 154 - 154
  • [8] Genetic Association of Short Sleep Duration With Hypertension Incidence - A 6-Year Follow-up in the Korean Genome and Epidemiology Study -
    Kim, Se Joong
    Lee, Seung Ku
    Kim, Seong Hwan
    Yun, Chang-Ho
    Kim, Je Hyeong
    Thomas, Robert J.
    Shin, Chol
    CIRCULATION JOURNAL, 2012, 76 (04) : 907 - 913
  • [9] The 6-year clinical outcomes for patients registered in a multiregional United States Kidney Paired Donation program - a retrospective study
    Stepkowski, Stanislaw M.
    Mierzejewska, Beata
    Fumo, David
    Bekbolsynov, Dulat
    Khuder, Sadik
    Baum, Caitlin E.
    Brunner, Robert J.
    Kopke, Jonathan E.
    Rees, Susan E.
    Smith, Connie
    Ashlagi, Itai
    Roth, Alvin E.
    Rees, Michael A.
    TRANSPLANT INTERNATIONAL, 2019, 32 (08) : 839 - 853
  • [10] Pediatric Tuberculosis Disease during Years of High Refugee Arrivals: A 6-Year National Prospective Surveillance Study
    Fritschi, Nora
    Schmidt, Axel J.
    Hammer, Jurg
    Ritz, Nicole
    RESPIRATION, 2021, 100 (11) : 1050 - 1059